Broadly Neutralizing Influenza Hemagglutinin Stem-Specific Antibody CR8020 Targets Residues that Are Prone to Escape due to Host Selection Pressure

Broadly neutralizing antibodies (bNAb) that target a conserved region of a viral antigen hold significant therapeutic promise. CR8020 is a bNAb that targets the stem region of influenza A virus (IAV) hemagglutinin (HA). CR8020 is currently being evaluated for prophylactic use against group 2 IAVs in...

Full description

Bibliographic Details
Main Authors: Tharakaraman, Kannan (Contributor), Subramanian, Vidya (Contributor), Cain, David (Contributor), Sasisekharan, Viswanathan (Contributor), Sasisekharan, Ram (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. School of Engineering (Contributor), MIT Skoltech Initiative (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Elsevier, 2015-10-29T18:54:31Z.
Subjects:
Online Access:Get fulltext